Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
About this trial
This is an interventional treatment trial for Type 1 Diabetes Mellitus focused on measuring diabetes, insulin pump, glulisine, aspart, glycemic index
Eligibility Criteria
Inclusion Criteria:
- Type 1 diabetes mellitus
- CSII for at least 3 months
- Duration of diabetes > 1 years
- Informed consent
Exclusion Criteria:
- Concomitant dietary restrictions (e.g. celiac disease or food allergy)
- Diabetes related complications
- Baseline hyperglycemia >150 mg/dl
- Any disease judged by the investigator to affect the trial
Sites / Locations
- Department of Pediatrics, Medical University of Warsaw, Poland
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
GLU_ASP
ASP_GLU
Pre-breakfast insulin was given as a standard bolus 15 minutes before the high-glycemic index meal (cornflakes and milk). The carbo-insulin ratio on both study days was identical to the patient's ratio when entering trial. First day: insulin glulisine Second day: insulin aspart
Pre-breakfast insulin was given as a standard bolus 15 minutes before the high-glycemic index meal (cornflakes and milk). The carbo-insulin ratio on both study days was identical to the patient's ratio when entering trial. First day: insulin aspart Second day: insulin glulisine